Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Follow-Up Review of the Food and Drug Administration's Generic Drug Approval Process

Issued on  | Posted on  | Report number: A-15-91-00025

Report Materials

EXECUTIVE SUMMARY:

This final audit report points out that the Food and Drug Administration (FDA) has not taken sufficient action to correct a material weakness in FDA's generic drug approval process. The FDA needs to: (1) modify the method by which generic drug applications are assigned to reviewers to remove any opportunity for showing partiality or favoritism; (2) revise its "first-in, first-reviewed" policy for generic drugs because the current policy may allow for the unequal treatment of drug firms' applications; (3) develop comprehensive guidelines to assure that generic drug applications are reviewed in a uniform and consistent manner; and (4) establish a quality control review system outside the Office of Generic Drugs to ensure the propriety of individual generic drug application reviews and the integrity of the review process.


-
-
-